Cardiff Oncology (CRDF)
(Delayed Data from NSDQ)
$4.07 USD
+0.08 (2.01%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.20 +0.13 (3.19%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Earnings News For CRDF
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
-
Cardiff Oncology: Q3 Earnings Snapshot
-
Cardiff Oncology Reports Third Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology: Q1 Earnings Snapshot
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
-
Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q3 Earnings Snapshot
-
Cardiff Oncology Reports Third Quarter 2022 Results and Provides Business Updates
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates
-
Cardiff Oncology: Q2 Earnings Snapshot
-
Cardiff Oncology Reports Second Quarter 2022 Results and Provides Business Updates
-
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Cardiff Oncology (CRDF) Reports Q1 Loss, Misses Revenue Estimates
-
Cardiff Oncology (CRDF) Reports Q4 Loss, Tops Revenue Estimates
-
Cardiff Oncology (CRDF) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Cardiff Oncology (CRDF) Reports Q3 Loss, Tops Revenue Estimates
-
Will Cardiff Oncology (CRDF) Report Negative Q3 Earnings? What You Should Know
-
Cardiff Oncology (CRDF) Reports Q2 Loss, Tops Revenue Estimates